The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

Obesity treatment can include GLP-1 medications, non-surgical procedures such as ESG stomach tightening and short-term gastric balloons, and traditional bariatric surgery. Here’s an alarming fact: 42% ...

Novo Nordisk has won the race to secure approval from the FDA for the first weight-loss drug to be administered orally ...

GLP-1 receptor agonists have captured global attention for their ability to drive weight loss and improve metabolic health.

The US FDA has approved Wegovy pill, the first oral GLP-1 drug for weight loss. With Ozempic already in India, experts say this signals a major shift in obesity care, raising hopes, questions on ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making ...

GLP-1 agonists are pivotal in obesity care, promoting weight loss and addressing related health issues, with a focus on ...

Congress has the power to make obesity treatment and weight management accessible to the communities that need it.

Extra body weight and too little activity are now among the top drivers of cancer. To keep cancer rates low in Utah, we need ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

Greece rolls out free obesity treatments and major preventive screening programs aimed at improving public health outcomes.

Children who respond well to pediatric obesity treatment have markedly lower morbidity and mortality risks in young adulthood, according to data published on January 21 in JAMA Pediatrics. Researchers ...